MedPath

tACS Intervention for Methamphetamine Addiction

Not Applicable
Completed
Conditions
Methamphetamine Use Disorder
Interventions
Device: Active transcranial alternating current stimulation
Device: Sham transcranial alternating current stimulation
Registration Number
NCT06288997
Lead Sponsor
Shanghai Mental Health Center
Brief Summary

A growing body of evidence suggests a wide range of brain areas are critical for regulating cognitive control over decisions and involving in drug related cue processing. Previous studies have demonstrated that transcranial alternating current stimulation (tACS) over prefrontal cortex reduces craving for meth dependences. In this study, the investigators investigated whether a current level of 15mA with a patented frequency of 77.5Hz tACS intervention of prefrontal cortex cortices in methamphetamine addiction could reduce the subjective craving and improve the cognitive abilities.

Detailed Description

The study will be conducted at the drug rehabilitation center in China. The whole procedure includes enrollment, pre-intervention evaluation, intervention (for 2 weeks, twice daily, 10 times a week, 20 times in total), post-intervention evaluation and one month follow up evaluation.

In enrollment session, participants are recruited according to inclusion criteria.

Sample size was calculated by GPower 3.1.9.4. As Hi-tACS has not been investigated in drug addiction, therefore, according to the previous study 'Transcranial alternating current stimulation for treating depression: a randomized controlled trial', the investigators choose the effect size as 1.2. After calculation, the sample size per group should be at least 20. A total of sample size should be 40. Considering the rate of drop-out during the treatment, the investigators set the sample size as 60 (30 per group).

In the pre-intervention evaluation, firstly, participants need complete a questionnaire to assess their demographic information, drug addiction history and drug abstinence. And then are assigned to either active group or sham group according to the counterbalance of their basic demographic and drug use information. Then, participants need complete craving, cognitive ability and electroencephalogram (EEG) assessment. For craving assessing, participants are shown a video of methamphetamine usage for 5 minutes, and then rated on the visual analogue scale (0 means completely undesired and 100 means extremely wanting) to report their craving for methamphetamine. For cognitive ability and EEG signal assessing, the whole process is conducted on the computer according to instructions.

In the intervention session, tACS stimulates the scalp with three Nexalin electrodes (Nexalin Technology, Inc., Houston, TX, USA): the locations of electrodes are determined according to international 10/20 system for EEG recording, and a 4.45 × 9.53cm electrode is placed above the forehead (Fpz, Fp1, and Fp2), the other two 3.18 × 3.81cm electrodes are placed above both mastoid areas. The active group received 77.5 Hz tACS for 40 minutes per session. The sham group received treatment with identical technical parameters, which induced scalp sensations but without penetration of the electric field into the brain.

Post-intervention evaluation and one month follow up evaluation are the same as in pre-intervention evaluation.

To ensure study quality, some measures are taken as bellow: Researchers and drug rehabilitation staff will work together in whole process and the data will be converted into electronic versions once finishing each evaluation.

In the intervention, patients, operators, and raters were blind to treatment condition. Each patient is assigned a tACS device (real or sham) and raters are not present while treatments are administered.

After each treatment times, any side effect from participant's report are recorded to assure the safety and feasibility.

Statistical analyses will be performed using R Studio and Matlab. The principal statistical analysis will be performed using the linear mixed effect model. For details, piecewise linear mixed effect models will be conducted according to the changes patterns of scores (craving, BIS, BDI, BAI, PSQI) over time. The interaction term will be included in the linear mixed effect models to describe the changing rate (slope) difference between treatment groups. Pairwise comparison for craving/BIS/BAI/BDI/PSQI reduction speed before and after the treatment period, and the comparisons of follow-up after treatment to baseline across treatment groups, will be evaluated through the piecewise linear mixed effect models. Linear models will be employed, after confirming the normality of score changes.

The Person's correlation and Spearman's correlation will be conducted to estimate the corraltion between symptoms and score changes. In addition, significant results identified will be checked for consistency and robustness.

All missing data will be recorded and marked.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Methamphetamine dependents
  • middle school degree or above
Exclusion Criteria
  • Have contraindications to rTMS (head trauma, epilepsy or history of epilepsy, metal implant etc.)
  • psychiatric illnesses
  • intellectual impairment (IQ<90)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active tACS groupActive transcranial alternating current stimulationIn the active group, the intervention is carried out using Hi-tACS with an intensive current of 15mA and a frequency of 77.5 Hz. Each intervention session lasts for 40 minutes, with two sessions conducted daily - one in the morning and one in the afternoon. The intervention is spread over a 10-day period, with sessions taking place five days per week, totaling two weeks.
Sham tACS groupSham transcranial alternating current stimulationThe sham group undergoes sessions with the same technical settings, designed to produce similar scalp sensations but without effective penetration of the electric field into the brain. Each session lasts for 40 minutes, with two sessions conducted daily - one in the morning and one in the afternoon. The intervention is spread over a 10-day period, with sessions taking place five days per week, totaling two weeks.
Primary Outcome Measures
NameTimeMethod
Subjective cravingThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

Subjective craving is measured by using Analogue Scale (VAS) for craving after watching video stimulus, ranging from 0 to 100, where 0 indicates no craving at all and 100 represents an extremely intense craving.

Objective cravingThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

Objective craving is measured by using the EEG recording to reflect the brain activity of individuals to the drug-related videos and pictures. EEG data were recorded when participants watch videos in Video-induced Craving Task (VCT) and when participants see pictures in Picture-induced Craving Task (PCT). The amplitude of late positive potential (LPP) was considered as a major outcome of the drug-cue related ERP, higher LPP is related to higher craving.

Secondary Outcome Measures
NameTimeMethod
Resting-state brain activityThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

based on resting-state EEG, the five power oscillations will be calculated (Delta band, Theta band, Alpha band, Beta band, and Gamma band).

Depression statusThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

The depression status is measured by Beck Depression inventory scale. The questionnaire is a 21-question multiple-choice self-report inventory, score ranged from 0 to 63, high score means worse depression.

Anxiety statusThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

Anxiety status is measured by Beck anxiety inventory scale,it consists of 21 self-reported items (four-point scale) used to assess the intensity of physical and cognitive anxiety symptoms. Scores may range from 0 to 63: minimal anxiety levels (0-7), mild anxiety (8-15), moderate anxiety (16-25), and severe anxiety (26-63). higher score means worse anxiety.

Sleep statusThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

Sleep status measured by Pittsburgh Sleep Quality Index scale (PSQI). The global PSQI score is calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.

ImpulsivityThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

Impulsivity is measured by Barratt Impulsiveness Scale, the total scores can range from 30 to 120. Higher score means higher impulsivity.

Uncertainty decision-makingThe day before intervention, the day after intervention, 2 weeks after intervention and 3 months after intervention.

Uncertainty decision-making ability is measured by using choice under risk and ambiguity. The score of probability for uncertainty choice is the major outcome, higher means more inclined to take risks. ERP (event-related potential) is also analyzed during decision-making. Higher amplitude of ERP means more inclined to take risks.

Trial Locations

Locations (5)

Hubei Shizishan Drug Rehabilitation Center

🇨🇳

Wuhan, Hubei, China

Da Lian Shan Institute of Addiction Rehabilitation

🇨🇳

Nanjing, Jiangsu, China

Tai Hu Institute of Addiction Rehabilitation

🇨🇳

Suzhou, Jiangsu, China

Sichuan Drug Rehabilitation Center

🇨🇳

Deyang, Sichuan, China

Beijing Tiantanghe Addiction Rehab Center

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath